Advertisement
Home2024-01-11T09:26:42-05:00

Top Story

Advertisement

Featured Webinars

Handpicked Promotions & Highlights

Latest in Catalyst News powered by BioPharmCatalyst

03/28/2024 04:45 PM ET

Reviva Pharmaceuticals Holdings RVPH date announcement

Now that the Phase 3 trial of Brilaroxazine - (RECOVER) is completed, Reviva Pharmaceuticals Holdings will announce their top-line results on December 31, 2024. As of now, the drug has a 60.5% chance of moving [...]

Read More
03/28/2024 04:45 PM ET

Avalo Therapeutics MIST date announcement

Milestone Pharmaceuticals has an announcement scheduled for June 30, 2024 regarding their recent NDA Filing trial of Etripamil - (RAPID). The community is currently bullish on the prospects of progression, as all four community members [...]

Read More
03/28/2024 04:45 PM ET

Atara Biotherapeutics ATRA earnings announcement

Atara Biotherapeutics revealed their most recent quarterly earnings data, in which both revenue and EPS ended up lower than estimates. EPS was estimated to be -$0.48, but the actual figure came in at -$0.56.

[...]

Read More
03/28/2024 04:45 PM ET

Candel Therapeutics CADL earnings announcement

Candel Therapeutics revealed their most recent quarterly earnings data, in which both revenue and EPS ended up lower than estimates. EPS, at -$0.38, was the biggest surprise for the quarter, as it missed [...]

Read More

Latest From Our Blog

Receive essential insights, resources and content direct to your inbox

Hit subscribe to stay informed!

Go to Top